N
JAZZ icon

Numerai’s Jazz Pharmaceuticals JAZZ Stock Holding History

Numerai’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.64M Buy
+13,984
New +$2.44M 0.27% 99
2025
Q2 		– Sell
-7,523
Closed -$934K – 547
2025
Q1 		$934K Buy
+7,523
New +$981K 0.18% 173

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Numerai's JAZZ Position: Q1 2026 in Review

Numerai opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 13,984 shares worth $2.64M. The stake represents 0.27% of the portfolio and ranks #99 among its holdings. This is a return to the name: Numerai previously reported a position in JAZZ as recently as Q1 2025.

Numerai first reported a position in JAZZ in Q1 2025 and has held it in 2 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Numerai held 13,984 shares of Jazz Pharmaceuticals worth $2.64M as of Q1 2026.
  • Jazz Pharmaceuticals was a new Numerai position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.27% of Numerai's portfolio in Q1 2026, its #99 holding.
  • Numerai first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Numerai's 13F filing for Q1 2026, filed 15 May 2026.